KalVista Pharmaceuticals, Inc. · HAM:4XC1
KalVista Pharmaceuticals, Inc. shareholders
KalVista Pharmaceuticals, Inc. on 6ix: holders from US fund reports; insider trades and big-stake notices reported in the US. Largest: The Arbitrage Fund, Emerald Growth Fund and BlackRock Health Sciences Opportunities Portfolio. Each with its filing.
| Holder | Shares | % of KalVista Pharmaceuticals, Inc. | Change | As of |
|---|---|---|---|---|
| The Arbitrage Fund | 691K | new | May 31, 2026 | |
| Emerald Growth Fund | 260K | Apr 30, 2026 | ||
| BlackRock Health Sciences Opportunities Portfolio | 213K | no change | May 29, 2026 | |
| Fidelity Extended Market Index Fund | 204K | −2,794 | May 31, 2026 | |
| Vanguard Russell 2000 Index Fund | 197K | +6,633 | May 31, 2026 | |
| Schwab U.S. Small-Cap ETF | 190K | +1,458 | May 31, 2026 | |
| AltShares Merger Arbitrage ETF | 90,263 | new | May 31, 2026 | |
| Vanguard Health Care Index Fund | 82,908 | −712 | May 31, 2026 | |
| iShares ESG Aware MSCI USA Small-Cap ETF | 76,735 | −5,729 | May 31, 2026 | |
| Fidelity Total Market Index Fund | 74,994 | no change | May 31, 2026 |